Literature DB >> 19701779

In vitro microscale systems for systematic drug toxicity study.

Jong Hwan Sung1, Michael L Shuler.   

Abstract

After administration, drugs go through a complex, dynamic process of absorption, distribution, metabolism and excretion. The resulting time-dependent concentration, termed pharmacokinetics (PK), is critical to the pharmacological response from patients. An in vitro system that can test the dynamics of drug effects in a more systematic way would save time and costs in drug development. Integration of microfabrication and cell culture techniques has resulted in 'cells-on-a-chip' technology, which is showing promise for high-throughput drug screening in physiologically relevant manner. In this review, we summarize current research efforts which ultimately lead to in vitro systems for testing drug's effect in PK-based manner. In particular, we highlight the contribution of microscale systems towards this goal. We envision that the 'cells-on-a-chip' technology will serve as a valuable link between in vitro and in vivo studies, reducing the demand for animal studies, and making clinical trials more effective.

Entities:  

Mesh:

Year:  2009        PMID: 19701779     DOI: 10.1007/s00449-009-0369-y

Source DB:  PubMed          Journal:  Bioprocess Biosyst Eng        ISSN: 1615-7591            Impact factor:   3.210


  15 in total

Review 1.  Microfabrication technologies for oral drug delivery.

Authors:  Shilpa Sant; Sarah L Tao; Omar Z Fisher; Qiaobing Xu; Nicholas A Peppas; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2011-12-04       Impact factor: 15.470

2.  A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells.

Authors:  Huanhuan Joyce Chen; Paula Miller; Michael L Shuler
Journal:  Lab Chip       Date:  2018-07-10       Impact factor: 6.799

Review 3.  Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.

Authors:  Uwe Marx; Tommy B Andersson; Anthony Bahinski; Mario Beilmann; Sonja Beken; Flemming R Cassee; Murat Cirit; Mardas Daneshian; Susan Fitzpatrick; Olivier Frey; Claudia Gaertner; Christoph Giese; Linda Griffith; Thomas Hartung; Minne B Heringa; Julia Hoeng; Wim H de Jong; Hajime Kojima; Jochen Kuehnl; Marcel Leist; Andreas Luch; Ilka Maschmeyer; Dmitry Sakharov; Adrienne J A M Sips; Thomas Steger-Hartmann; Danilo A Tagle; Alexander Tonevitsky; Tewes Tralau; Sergej Tsyb; Anja van de Stolpe; Rob Vandebriel; Paul Vulto; Jufeng Wang; Joachim Wiest; Marleen Rodenburg; Adrian Roth
Journal:  ALTEX       Date:  2016-05-15       Impact factor: 6.043

4.  Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.

Authors:  David E Watson; Rosemarie Hunziker; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2017-10

Review 5.  Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component?

Authors:  Kevin J Cyr; Omero M Avaldi; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2017-11

Review 6.  In vitro platforms for tissue engineering: implications for basic research and clinical translation.

Authors:  Jeroen Rouwkema; Susan Gibbs; Matthias P Lutolf; Ivan Martin; Gordana Vunjak-Novakovic; Jos Malda
Journal:  J Tissue Eng Regen Med       Date:  2011-02-24       Impact factor: 3.963

Review 7.  Organ-on-a-chip platforms for studying drug delivery systems.

Authors:  Nupura S Bhise; João Ribas; Vijayan Manoharan; Yu Shrike Zhang; Alessandro Polini; Solange Massa; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

Review 8.  Accelerating drug discovery via organs-on-chips.

Authors:  Chung Yu Chan; Po-Hsun Huang; Feng Guo; Xiaoyun Ding; Vivek Kapur; John D Mai; Po Ki Yuen; Tony Jun Huang
Journal:  Lab Chip       Date:  2013-12-21       Impact factor: 6.799

Review 9.  Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.

Authors:  A Chen; M L Yarmush; T Maguire
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

10.  Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.

Authors:  Felipe T Lee-Montiel; Alexander Laemmle; Verena Charwat; Laure Dumont; Caleb S Lee; Nathaniel Huebsch; Hideaki Okochi; Matthew J Hancock; Brian Siemons; Steven C Boggess; Ishan Goswami; Evan W Miller; Holger Willenbring; Kevin E Healy
Journal:  Front Pharmacol       Date:  2021-05-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.